Westlake Chemical Co

WLK
Delayed Nyse - 04/06 10:10:00 pm
39.04USD
+11.16%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2019 2020 (e)
Sales 8 118 7 553
EBITDA 1 407 1 178
Operating profit (EBIT) 656 434
Pre-Tax Profit (EBT) 570 307
Net income 421 219
P/E ratio 21,6x 20,7x
EPS ( $ ) 3,25 1,70
Dividend per Share ( $ ) 1,03 1,05
Yield 1,46% 2,98%
Reference price ( $ ) 70,150 35,200
Announcement Date 02/18/2020
11:30am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2019 2020 (e)
Debt 2 717 2 314
Finance - -
Operating income (EBITDA) 1 407 1 178
Leverage
(Debt/EBITDA)
1,93x 1,96x
Capital Expenditure 787 701
Free Cash Flow (FCF) 514 436
Book Value Per Share (BVPS) ( $ ) 45,6 62,0
Cash Flow per Share ( $ ) 10,1 10,2
Announcement Date 02/18/2020
11:30am
-
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 4 519 M $ -
Entreprise Value (EV) 6 833 M $ 6 710 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 20,7x 14,1x
Capitalization / Revenue 0,60x 0,58x
EV / Revenue 0,90x 0,87x
EV / EBITDA 5,80x 5,38x
Yield (DPS / Price) 2,98% 3,13%
Price to book (Price / BVPS) 0,57x 0,55x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 5,75% 5,97%
Operating Leverage (Delta EBIT / Delta Sales) -4,86x 2,05x
Net Margin (Net Profit / Revenue) 2,90% 4,09%
ROA (Net Profit / Asset) 1,97% 2,85%
ROE (Net Profit / Equities) 4,30% 5,71%
Rate of Dividend 61,7% 44,2%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   9,28% 8,01%
Cash Flow / Sales 17,3% 16,1%
Capital Intensity (Assets / Sales) 1,47x 1,43x
Financial Leverage (Net Debt / EBITDA) 1,96x 1,73x
Price Earning Ratio
BNA & Dividende